Maternal serum inhibin-A for predicting preeclampsia

References

• Brown MA, Lindheimer MD, de Swiet M, Van Assche A and Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy:statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• Robert JM, Cooper DW. Pathogenesis and genetic of preeclampsia. Lancet 2005;357:53–56.
   Google Scholar
• Salomon LJ, Benattar C, Audibert F. Severe preeclampsia is associated with high inhibin-A levels and abnormal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517–1522.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Kamel S, Ohkubo A, Yamanaka M, Makino K, Tokudo K. Urinary protein as measured with pyrogallol red-molybdate complex, manually and in a Hitachi automated analyzer. Clin Chem 1986;32:1551–1554.
   PubMed Web of Science ®Google Scholar
• Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan S, Baird DT, McNeilly AS. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994;40:717–723.
   PubMed Web of Science ®Google Scholar
• Petrie A, Sabin C. Medical statistics at a glance. 2nd ed. Malden, Mass. Oxford: Blackwell; 2005.
   Google Scholar
• Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004;111:298–302.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–192.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104:1367–1391.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, Lucinda J, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. Circulating angiogenic factors and the risk of preeclampsia. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Qudejans CBM, Van Vugt JMG, Blankenstein MA, Van Wijk J. Markers for pre-symptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy 2004;23:171–189.
   PubMed Web of Science ®Google Scholar
• Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002;109:759–764.
   PubMed Web of Science ®Google Scholar
• Petraglia F, Sawchenko P, Lim ATW, Vale W. Localization, secretion and action of inhibin in human placenta. Science 1987;237:189–192.
   Google Scholar
• Robertson DM, Foulds LM, Leversha L. Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun 1985;126:220–226.
   PubMed Web of Science ®Google Scholar
• Petraglia F, Calza' L, Garuti GC. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990;71:487–492.
   PubMed Web of Science ®Google Scholar
• Rabinovici J, Goldsmith PC, Librach CL. Localization and regulation of the activin-A dimer in human placental cells. J Clin Endocrinol Metab 1992;75:571–576.
   PubMedGoogle Scholar
• Petraglia F, Anceschi MM, Calza' L. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993;77:542–548.
   PubMed Web of Science ®Google Scholar
• Petraglia F, Garg S, Florio P, Sadick M, Gallinelli A, Wong WL, Krummen L, Comitini G, Mather J, Woodruff TK. Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy. Endocr J 1993;1:323–327.
   Google Scholar
• Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro _C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089–1093.
   PubMedGoogle Scholar
• Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Ellis PM, Aitken DA, Groome NP. Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997;82:218–222.
   PubMedGoogle Scholar
• Luisi S, Battaglia C, Florio P, D'Ambrogio G, Taponeco F, Santuz M, Genazzani AR, Petraglia F. Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, maternal serum in early pregnancy. Placenta 1998;19:435–438.
   PubMedGoogle Scholar
• Petraglia S, Luisi S, Benedetto C. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab 1997;82:2991–2995.
   PubMedGoogle Scholar
• Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with Preeclampsia. BMJ 2000;107:795–797.
   Google Scholar
• Salomon LJ, Benattar C, Audibert F, Fernandez H, Duyme M, Taieb J, Frydman R. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517–1522.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Roes EM, Gaytant MA, Thomas CMG, Raijmakers MTM, Zusterzeel PLM, Peters WHM, Steegers EAP. First trimester inhibin-A concentrations and later development of preeclampsia. Acta Obstet Gynecol Scand 2004;83:117.
   PubMedGoogle Scholar
• D'anna R, Baviera G, Corrado F, Leonardi L, Buemi M, Jasonni VM. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand 2002;81:540–543.
   PubMed Web of Science ®Google Scholar
• Morpurgo PS, Cetin I, Borgato S, Cortelazzi D, Nobile-DeSantis MS, Vaghi I, Beck-Peccoz P. Circulating levels of inhibin A, inhibin B and activin A in normal and intrauterine growth restricted (IUGR) fetuses. Eur J Obstet Gynecol Reprod Biol 2004;117:38–44.
   PubMedGoogle Scholar
• Itoh Y, Suzuki Y, Yamamoto T, Kojima K, Murakami I, Suzumor N. Increase in serum concentrations of inhibin in early onset preeclampsia with intrauterine growth restriction. J Obstet Gynecol Res 2006;32:80–85.
   Google Scholar
• Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert-Messerlian G, Severi FM, Petraglia F. Preeclampsia with fetal growth restriction: placental and serum activin A levels. Gynecol Endocrinol 2002;16:365–372.
   PubMed Web of Science ®Google Scholar
• Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669–674.
   PubMedGoogle Scholar
• Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3–19.
   PubMed Web of Science ®Google Scholar
• Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:365–372.
   PubMedGoogle Scholar
• Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991;12:301–308.
   PubMed Web of Science ®Google Scholar
• Kim SY, Ryu HM, Yang JH, Kim MY, Ahn HK, Shin JK, Choi JK, Park SY, Kim JM, Lee BY, Kim DJ. Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. J Korean Med Sci 2006;21:452–456.
   PubMed Web of Science ®Google Scholar